Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tandem Diabetes Care (TNDM) EBT Margin (2016 - 2025)

Tandem Diabetes Care's EBT Margin history spans 13 years, with the latest figure at 1.63% for Q4 2025.

  • For Q4 2025, EBT Margin rose 162.0% year-over-year to 1.63%; the TTM value through Dec 2025 reached 19.73%, down 996.0%, while the annual FY2025 figure was 19.74%, 997.0% down from the prior year.
  • EBT Margin reached 1.63% in Q4 2025 per TNDM's latest filing, up from 10.09% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 5.29% in Q4 2021 to a low of 72.96% in Q1 2023.
  • Average EBT Margin over 5 years is 14.49%, with a median of 9.71% recorded in 2022.
  • Peak YoY movement for EBT Margin: crashed -6364bps in 2023, then skyrocketed 5234bps in 2024.
  • A 5-year view of EBT Margin shows it stood at 5.29% in 2021, then plummeted by -239bps to 7.33% in 2022, then crashed by -117bps to 15.91% in 2023, then soared by 100bps to 0.01% in 2024, then soared by 15240bps to 1.63% in 2025.
  • Per Business Quant, the three most recent readings for TNDM's EBT Margin are 1.63% (Q4 2025), 10.09% (Q3 2025), and 23.98% (Q2 2025).